Neuroendocrine control of natural killer cell function through the checkpoint molecule PD-1

被引：0
|
作者：
Justine Devulder
Anne Tsicopoulos
Catherine Duez
机构：
[1] Institut National de la Santé Et de la Recherche Médicale,Pulmonary Immunity
[2] U1019,Institut Pasteur de Lille
[3] Center for Infection and Immunity of Lille,undefined
[4] CNRS UMR 8204,undefined
[5] Univ Lille Nord de France,undefined
[6] Clinique des Maladies Respiratoires et Centre Hospitalier Régional et Universitaire de Lille,undefined
来源：
Cellular & Molecular Immunology | 2019年 / 16卷
关键词：
Neuroendocrine Control; MCMV Infection; Quatrini; Murine Cytomegalovirus; Reduce Pathogen Burden;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 111
页数：2
相关论文
共 50 条
  • [21] PD-1 Is Expressed at Low Levels on All Peripheral Blood Natural Killer Cells but Is a Significant Suppressor of NK Function Against PD-1 Ligand Expressing Tumor Targets
    Davis, Zachary
    Felices, Martin
    Lenvik, Todd R.
    Badal, Sujan
    Hinderlie, Peter
    Blazar, Bruce R.
    Vallera, Daniel A.
    Miller, Jeffrey S.
    BLOOD, 2019, 134
  • [22] Transcriptional Control of Natural Killer Cell Development and Function
    Hesslein, David G. T.
    Lanier, Lewis. L.
    ADVANCES IN IMMUNOLOGY, VOL 109, 2011, 109 : 45 - 85
  • [23] Transcriptional control of natural killer cell differentiation and function
    Alfonso Martín-Fontecha
    Graham M. Lord
    Hugh J. M. Brady
    Cellular and Molecular Life Sciences, 2011, 68 : 3495 - 3503
  • [24] Transcriptional control of natural killer cell differentiation and function
    Martin-Fontecha, Alfonso
    Lord, Graham M.
    Brady, Hugh J. M.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2011, 68 (21) : 3495 - 3503
  • [25] Emerging concepts in PD-1 checkpoint biology
    Pauken, Kristen E.
    Torchia, James A.
    Chaudhri, Apoorvi
    Sharpe, Arlene H.
    Freeman, Gordon J.
    SEMINARS IN IMMUNOLOGY, 2021, 52
  • [26] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Justin C. Moser
    Siwen Hu-Lieskovan
    Drugs, 2020, 80 : 459 - 465
  • [27] PD-1/PD-L1 checkpoint in hematological malignancies
    Annibali, O.
    Crescenzi, A.
    Tomarchio, V.
    Pagano, A.
    Bianchi, A.
    Grifoni, A.
    Avvisati, G.
    LEUKEMIA RESEARCH, 2018, 67 : 45 - 55
  • [28] Mechanisms of Resistance to PD-1 Checkpoint Blockade
    Moser, Justin C.
    Hu-Lieskovan, Siwen
    DRUGS, 2020, 80 (05) : 459 - 465
  • [29] PD-1 checkpoint inhibition: Toxicities and management
    Hahn, Andrew W.
    Gill, David M.
    Agarwal, Neeraj
    Maughan, Benjamin L.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 35 (12) : 701 - 707
  • [30] A new checkpoint for Natural Killer cell activation
    Souza-Fonseca-Guimaraes, Fernando
    Huntington, Nicholas D.
    IMMUNOLOGY AND CELL BIOLOGY, 2018, 96 (01): : 5 - 7
12345